We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Product
Advertisement

Antibody Pairs: High Sensitivity Verified by Cultured Virus Detection

Antibody Pairs: High Sensitivity Verified by Cultured Virus Detection


ACROBiosystems’ matched antibody pairs are specifically designed and screened for antigen detection kit development, which are suitable for different diagnostic assays, such as chemiluminescent immunoassay, ELISA, gold immunochromatography assay, etc.

The sensitivity of the sandwich ELISA can be as low as 12 pg/mL in the verification study using recombinant antigens. In addition, the antibody pairs have been verified using inactivated virus samples. The titer, which was determined using our LFA assay, is as low as 5 TCID50.

Free samples are available now >>>
*free sample are limited, first come first serve policy applied.

Nucleocapsid protein
NUN-S91     NUN-S92

S1 protein
S1N-M12A1   S1N-M13A1

These antibodies were recommended for antigen detection by double antibody sandwich.

>>>  Virus lysis buffer (Cat.No. LY-13) is available for antigen detection kit development.
>>>  If you have any bulk order inquiry, please feel free to click here.

We highly recommend ACROBiosystems’ RBD or N antibody pairs for antigen detection for SARS-CoV-2 diagnostic kits.

Request Free samples >>>


About ACROBiosystems
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed for discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated to innovation to simplify and accelerate the development of new, better, and more affordable medicine. Our way of addressing challenges in biologics development is to offer a comprehensive array of tools and solutions designed for each development phase. Starting from discovery and development and moving beyond commercialization, we strive to deliver high-quality solutions that support each step of the development process. This means bringing together innovation and technology through product development and collaborations to help our customers achieve translatable results in the clinic and beyond.
Interested in seeing more content from ACROBiosystems ?
Discover all their latest news, webinars, products and more by clicking the link below.